What Does FSD Pharma Have To Offer??Here's one question ----What does FSD Pharma have to offer Pfizer? Pfizer's Lyrica which was approved in 2004 had a long multi-billion run until their patent expired on December 30th, 2018. They were not successful in stopping the FDA from approving generic brands from 10 different drug makers in July 2019. But there is a silver lining to this story ---the drug is Pfizer's main patent expiring in 2026 giving them time to rebrand Lyrica. A safer more effective Lyrica will be a major GAME CHANGER in Pfizer's future. In the world of big pharma ----no one wants to give up their big share of the pie. GLTA